Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf
Acinetobacter baumannii is an important pathogen in hospital acquired infections. Although tigecycline currently remains a potent antibiotic for treating infections caused by multidrug resistant A. baumannii (MDRAB) strains, reports of tigecycline resistant isolates have substantially increased. The...
| Glavni autori: | , , , , , , , , , , , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Taylor & Francis Group
2021-01-01
|
| Serija: | Emerging Microbes and Infections |
| Teme: | |
| Online pristup: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1948804 |